Patents Assigned to CereSpir Incorporated
  • Patent number: 11717516
    Abstract: Co-crystals of itanapraced; methods of preparation of the co-crystals; uses of the co-crystals as APIs; formulations containing the co-crystals; uses of the co-crystals and formulations for prevention and treatment of neurodegeneration disorders, infections, dementias, inflammation, and injuries; and methods of prevention and treatment of neurodegeneration disorders, infections, dementias, inflammation, and injuries are described.
    Type: Grant
    Filed: October 25, 2022
    Date of Patent: August 8, 2023
    Assignee: CereSpir Incorporated
    Inventors: Daniel G. Chain, Ronald Mueller
  • Publication number: 20230113097
    Abstract: Co-crystals of itanapraced; methods of preparation of the co-crystals; uses of the co-crystals as APIs; formulations containing the co-crystals; uses of the co-crystals and formulations for prevention and treatment of neurodegeneration disorders, infections, dementias, inflammation, and injuries; and methods of prevention and treatment of neurodegeneration disorders, infections, dementias, inflammation, and injuries are described.
    Type: Application
    Filed: August 29, 2022
    Publication date: April 13, 2023
    Applicant: CereSpir Incorporated
    Inventors: Daniel G. Chain, Ronald Mueller